Top-News

Unigene Labs News

Keine aktuellen Kursdaten verfügbar
WKN: 875852
ISIN: US9047531002
US-Symbol: UGNEQ
Typ: Aktie

Unigene Labs News

14.05.13 - PR Newswire
Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update
Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update -Management to host conference call on May 14, 2013 at 11 a.m. ET- PR Newswire
09.05.13 - PR Newswire
Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs Agreement Provides Unigene with Immediate ...
17.04.13 - PR Newswire
Victory Park Capital Completes Public Auction of Unigene's Peptelligence™ Drug Delivery Platform
Victory Park Capital Completes Public Auction of Unigene's Peptelligence™ Drug Delivery Platform PR Newswire
12.03.13 - PR Newswire
Unigene Announces Fourth Quarter and Full-Year 2012 Results
Unigene Announces Fourth Quarter and Full-Year 2012 Results -Management to host conference call on March 12, 2013 at 11 a.m. ET- PR Newswire
06.03.13 - PR Newswire
Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin
Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin PR Newswire
13.02.13 - PR Newswire
Unigene Receives 2013 Drug Delivery Partnerships Industry Achievement Award
Unigene Receives 2013 Drug Delivery Partnerships Industry Achievement Award For Second Consecutive Year, Unigene's Clinical Advances in the Oral Delivery of Peptides ...
13.02.13 - PR Newswire
Unigene Recieves 2013 Drug Delivery Partnerships Industry Achievement Award
Unigene Recieves 2013 Drug Delivery Partnerships Industry Achievement Award For Second Consecutive Year, Unigene's Clinical Advances in the Oral Delivery of Peptides ...
27.11.12 - PR Newswire
Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-​Engineered" TXA127 - Licensing Agreement Follows Successful Completion of ...
20.11.12 - PR Newswire
Unigene Announces Third Quarter 2012 Corporate Update
Unigene Announces Third Quarter 2012 Corporate Update -Third Quarter Highlighted by Forbearance Agreement and First Amendment to Amended and Restated Financing ...
16.11.12 - PR Newswire
Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012
Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012 PR Newswire
16.10.12 - PR Newswire
Unigene's Licensee, Tarsa Therapeutics, Reports Positive Clinical Data in Phase 2 Study of Oral Calcitonin for Prevention of Postmenopausal Osteoporosis
Unigene's Licensee, Tarsa Therapeutics, Reports Positive Clinical Data in Phase 2 Study of Oral Calcitonin for Prevention of Postmenopausal Osteoporosis Results Presented at ...
15.10.12 - PR Newswire
Unigene's Oral PTH Program Featured at ASBMR 2012 Annual Meeting
Unigene's Oral PTH Program Featured at ASBMR 2012 Annual Meeting Oral Presentation and Poster Sessions to Highlight Positive Phase 2 Results of Oral PTH for the Treatment ...
26.09.12 - PR Newswire
Unigene to Target Partnering and Therapeutic Development Opportunities Following Victory Park Capital Debt Financing and Forbearance
Unigene to Target Partnering and Therapeutic Development Opportunities Following Victory Park Capital Debt Financing and Forbearance - Victory Park Capital provides relief from ...
15.08.12 - PR Newswire
Unigene And Nordic Bioscience Announce Preliminary Selection Of Lead Compound For Treating Type 2 Diabetes
Unigene And Nordic Bioscience Announce Preliminary Selection Of Lead Compound For Treating Type 2 Diabetes -Unigene and Nordic Bioscience to Advance Proprietary Peptide ...
26.07.12 - PR Newswire
Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-​Containing Medicines -In response to recommendation regarding use of calcitonin-​containing ...
28.06.12 - PR Newswire
Unigene's Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
Unigene's Oral PTH Phase 2 Proof-​of-Concept Data to be Presented at Upcoming Scientific Conferences Data from Phase 2 Study Highlighted Among Presentations at the 5th ...
17.03.09 - ots
EANS-News: Unigene Laboratories Inc. / Unigene gibt ...
EANS-News: Unigene Laboratories Inc. / Unigene gibt Finanzergebnisse für 4. Quartal 2008 und für das Geschäftsjahr 2008 bekannt Unigene Finanzergebnis 4. Quartal 2008 und ...
18.03.08 - ots
ots: Unigene gibt Finanzergebnisse für 4. Quartal 2007 und für ...
Unigene gibt Finanzergebnisse für 4. Quartal 2007 und für das Geschäftsjahr 2007 bekannt: Einnahmen 2007 steigen um 237% auf 20.4 Mio USD ---------------------------------------------...
30.03.06 - Aktiencheck
Unigene dabeibleiben - Der Aktionär
21.03.06 - Aktiencheck
Unigene wieder attraktiv - Biotech-Report

Newssuche

Videos

newspaper
25.04.24 +21,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »